Lara Pharm Ltd develops pharmaceutical-grade cannabinoids and related technology. By developing a way to mass-produce standardized cannabis-based prescription drugs,Lara Pharmseeks to eliminate the need for medical marijuana. The company has developed an inhaler that delivers a controlled dose of cannabinoids.
Lara Pharm was acquired by Israeli Therapix Biosciences Ltd. (TASE: TRPH, formerly NasVax), back in August 2014.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Lara Pharm Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 27, 2015
www.greenprophet.com
LaraPharm's dry-powder inhaler delivers cannabis like a medicine - Green Prophet
undefined
Aug 11, 2014
www.globes.co.il
Therapix jumps on cannabis pharmaceutical acquisition